Celia Lin, M.D.

Celia Lin, M.D.

Former Chief Medical OfficeratVera Therapeutics· In proxies 2022–2023

Pay in FY2023-36% from the year before · Vera Therapeutics stock -20.5% the same year

Celia Lin, M.D. was paid $1.0M in FY2023 (Dec), down 36%. Vera Therapeutics stock fell 20.5% that year.

Pay$100 in the stock at the end of FY21 → $58
Pay is from the Summary Compensation Table of each Vera Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vera TherapeuticsPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role +37%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?